[1] Marchesini G,Bugianesi E,Forlani G,et al. Nonalcoholic fatty liver,steatohepatitis and the metabolic syndrome. Hepatology,2003,37(4):917-923. [2] Milic S,Stimac D. Nonalcoholic fatty liver disease/steatohepatitis:epidemiology,pathogenesis,clinical presentation and treatment. Dig Dis,2012,30(2):158-162. [3] White DL,Kanwal F,El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer,based on systematic review. Clin Gastroenterol Hepatol,2012,10(12):1342-1359. [4] Kalra S,Vithalani M,Gulati G,et al. Study of prevalence of nonalcoholic fatty liver disease(NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Physicians India,2013,61(7):448-453. [5] Guleria A,Duseja A,Kalra N,et al. Patients with non-alcoholic fatty liver disease(NAFLD) have an increased risk of atherosclerosis and cardiovascular disease. Trop Gastroenterol,2013,34(2):74-82. [6] Lankarani KB,Mahmoodi M,Lotfi M,et al. Common carotid intima-media thickness in patients with non-alcoholic fatty liver disease:a population-based case-control study. Korean J Gastroenterol,2013,62(6):344-351. [7] 中华医学会肝病分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版).胃肠病和肝病学杂志,2010,19(6):483-487. [8] 国家技术监督局.中华人民共和国国家标准. 中医临床诊疗术语. 北京:中国标准出版社,1997.12. [9] 中国医师协会超声医师分会.血管和浅表器官超声检查指南. 北京:人民军医出版社,2011:26. [10] 凌嫚芝,孔莹. 化痰祛瘀法治疗脂肪肝之证治探讨. 陕西中医,2013,34(6):736-737. [11] 潘丰满,杨钦河,沈英森,等. 祛湿活血法为主在脂肪肝治疗中的应用. 四川中医,2004,22(6):23. [12] 宋剑南. 气在痰瘀相关过程中的物质基础. 中医杂志,2001, 42(4):242-243. [13] Ma KL,Ruan XZ,Powis SH,et al. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology,2008,48(3):770-781. [14] Komorovsky R,Desideri A.Carotid ultrasound assessment of patients with coronary artery disease:a useful index for risk stratification.Vasc Health Risk Manag,2005,1(2):131-136. [15] 陈黎, 蒋阳昆, 林海,等. 非酒精性脂肪性肝病痰瘀证与代谢综合征的关系. 中国中西医结合消化杂志,2013,34(6):736-737. |